Zhen-Ao Group’s Breakthrough in the TALENTs Clinical Study
Zhen-Ao Group has recently reached an important scientific milestone in the field of healthy aging through its participation in the internationally recognized TALENTs Study—a multi-center, randomized, double-blind, placebo-controlled clinical trial conducted in collaboration with leading academic institutions, including Peking University.
The TALENTs Study was designed to investigate whether targeted nutritional strategies could support biological function and vitality in aging populations. By applying rigorous clinical methodology, the study represents a meaningful step forward in translating aging biology into evidence-based nutritional research.
Zhen-Ao Bio-Tech’s Scientific Contribution
As a core subsidiary of Zhen-Ao Group, Dalian Zhen-Ao Bio-Tech Co., Ltd. proudly served as the supplier of the study’s proprietary 5′-Nucleotide ingredients.
These nucleotides were produced using Zhen-Ao Bio-Tech’s advanced precision fermentation and enzymatic extraction platforms, ensuring high purity, consistency, and traceability. The ingredients were specifically developed to meet the stringent quality and reproducibility requirements of human clinical research.
Within the TALENTs Study framework, nucleotides were explored as a novel nutritional intervention with the potential to support cellular metabolism, cognitive function, and overall vitality during aging—areas of growing interest within longevity and healthspan research.
Scientific Significance of the TALENTs Findings
The positive outcomes observed in the TALENTs Study provide robust human clinical evidence supporting the role of nucleotides in aging-related nutritional science. Importantly, the study does not position nucleotides as a cure or reversal of aging, but rather highlights their potential role in modulating biological pathways associated with cellular function and age-related decline.
These findings reinforce the emerging view that aging is a complex, multi-system process—and that targeted nutrition may play a meaningful role in supporting healthy function over time when guided by rigorous scientific validation.
A Platform for Translational Longevity Science
For Zhen-Ao Group, TALENTs represents more than a single study. It reflects a broader, long-term strategy to build a science-driven biotechnology platform centered on yeast-derived bioactives, nucleotides, and cellular nutrition.
Zhen-Ao Bio-Tech will continue to expand its research collaborations with academic institutions and global partners, advancing translational studies that explore how nucleotide science and yeast-based bioactives can be responsibly applied across human health, nutrition, and longevity-focused research.
By integrating upstream fermentation technology, downstream functional insight, and clinical-grade evidence generation, Zhen-Ao aims to contribute meaningfully to the future of healthy aging—grounded in data, not speculation.
About Dalian Zhen-Ao Bio-Tech Co., Ltd.
Dalian Zhen-Ao Bio-Tech Co., Ltd. is a core subsidiary of Zhen-Ao Group, specializing in the research, development, and production of Ribonucleic Acid (RNA), 5′-Nucleotides, Yeast Extracts, and Functional Yeast Proteins.
With globally advanced fermentation and extraction platforms, Zhen-Ao Bio-Tech serves partners across the food & beverage, nutrition, pharmaceutical, and health industries. The company is committed to delivering high-quality, science-backed ingredients that support natural health, functional nutrition, and sustainable innovation—meeting the highest international standards for quality, safety, and regulatory compliance.
